Header Logo

Connection

Dongsheng Guo to Humans

This is a "connection" page, showing publications Dongsheng Guo has written about Humans.
Connection Strength

0.231
  1. Guo D, Daman K, Chen JJ, Shi MJ, Yan J, Matijasevic Z, Rickard AM, Bennett MH, Kiselyov A, Zhou H, Bang AG, Wagner KR, Maehr R, King OD, Hayward LJ, Emerson CP. iMyoblasts for ex vivo and in vivo investigations of human myogenesis and disease modeling. Elife. 2022 01 25; 11.
    View in: PubMed
    Score: 0.030
  2. Guo D, Liu H, Ruzi A, Gao G, Nasir A, Liu Y, Yang F, Wu F, Xu G, Li YX. Modeling Congenital Hyperinsulinism with ABCC8-Deficient Human Embryonic Stem Cells Generated by CRISPR/Cas9. Sci Rep. 2017 06 09; 7(1):3156.
    View in: PubMed
    Score: 0.022
  3. Guo D, Wu F, Liu H, Gao G, Kou S, Yang F, Abbas N, Zhou T, Cai X, Zhang H, Qin D, Li J, Xu K, Li YX. Generation of non-integrated induced pluripotent stem cells from a 59-year-old female with multiple endocrine neoplasia type 1 syndrome. Stem Cell Res. 2017 01; 18:64-66.
    View in: PubMed
    Score: 0.021
  4. Guo D, Liu H, Gao G, Liu Y, Zhuang Y, Yang F, Wang K, Zhou T, Qin D, Hong L, Li J, Xu K, Li YX. Creating a patient carried Men1 gene point mutation on wild type iPSCs locus mediated by CRISPR/Cas9 and ssODN. Stem Cell Res. 2017 01; 18:67-69.
    View in: PubMed
    Score: 0.021
  5. Guo D, Wu F, Liu H, Gao G, Kou S, Yang F, Abbas N, Zhou T, Cai X, Zhang H, Qin D, Li J, Xu K, Li YX. Generation of non-integrated induced pluripotent stem cells from a 23-year-old male with multiple endocrine neoplasia type 1 syndrome. Stem Cell Res. 2017 01; 18:70-72.
    View in: PubMed
    Score: 0.021
  6. Guo D, Liu H, Gao G, Ruzi A, Wang K, Wu H, Lai K, Liu Y, Yang F, Lai L, Li YX. Generation of an Abcc8 homozygous mutation human embryonic stem cell line using CRISPR/Cas9. Stem Cell Res. 2016 11; 17(3):640-642.
    View in: PubMed
    Score: 0.021
  7. Guo D, Liu H, Gao G, Ruzi A, Wang K, Wu H, Lai K, Liu Y, Yang F, Lai L, Li YX. Generation of an Abcc8 heterozygous mutation human embryonic stem cell line using CRISPR/Cas9. Stem Cell Res. 2016 11; 17(3):670-672.
    View in: PubMed
    Score: 0.021
  8. Liu P, Ponnienselvan K, Nyalile T, Oikemus S, Joynt AT, Iyer S, Kelly K, Guo D, Kyawe PP, Vanderleeden E, Redick SD, Huang L, Chen Z, Lee JM, Schiffer CA, Harlan DM, Wang JP, Emerson CP, Lawson ND, Watts JK, Sontheimer EJ, Luban J, Wolfe SA. Increasing intracellular dNTP levels improves prime editing efficiency. Nat Biotechnol. 2025 Apr; 43(4):539-544.
    View in: PubMed
    Score: 0.009
  9. Cheng Z, Guo D, Ruzi A, Pan T, You K, Chen Y, Huang X, Zhang J, Yang F, Niu L, Xu K, Li YX. Modeling MEN1 with Patient-Origin iPSCs Reveals GLP-1R Mediated Hypersecretion of Insulin. Cells. 2022 08 03; 11(15).
    View in: PubMed
    Score: 0.008
  10. Xu G, Wu F, Gu X, Zhang J, You K, Chen Y, Getachew A, Zhuang Y, Zhong X, Lin Z, Guo D, Yang F, Pan T, Wei H, Li YX. Direct Conversion of Human Urine Cells to Neurons by Small Molecules. Sci Rep. 2019 11 13; 9(1):16707.
    View in: PubMed
    Score: 0.006
  11. Iyer S, Suresh S, Guo D, Daman K, Chen JCJ, Liu P, Zieger M, Luk K, Roscoe BP, Mueller C, King OD, Emerson CP, Wolfe SA. Precise therapeutic gene correction by a simple nuclease-induced double-stranded break. Nature. 2019 04; 568(7753):561-565.
    View in: PubMed
    Score: 0.006
  12. Liu Y, Wu F, Liu D, Wei R, Abbas N, Xia J, Li D, Wang H, Zhuang Y, Guo D, Chen Y, Wu Y, Ke X, Tao J, Yang F, Lai K, Shu X, Li YX. Generation of WAe001-A-15, a human embryonic stem cell line with miR-122 doxycycline-inducible expression. Stem Cell Res. 2018 05; 29:84-87.
    View in: PubMed
    Score: 0.006
  13. Xu G, Guo D, Wu F, Abbas N, Lai K, Yuan F, You K, Liu Y, Zhuang Y, Wu Y, Xu Y, Chen Y, Yang F, Pan T, Li YX. Generation of a GDE heterozygous mutation human embryonic stem cell line WAe001-A-14 by CRISPR/Cas9 editing. Stem Cell Res. 2018 03; 27:38-41.
    View in: PubMed
    Score: 0.006
  14. Yuan F, Guo D, Liu Y, Xu Y, Gao G, Wu Y, Yang F, Ke X, Lai K, Wei H, Li YX. Generation of an ASS1 heterozygous knockout human embryonic stem cell line, WAe001-A-13, using CRISPR/Cas9. Stem Cell Res. 2018 01; 26:67-71.
    View in: PubMed
    Score: 0.006
  15. Yuan F, Guo D, Gao G, Liu Y, Xu Y, Wu Y, Yang F, Ke X, Lai K, Hong L, Li YX. Generation of a KCNJ11 homozygous knockout human embryonic stem cell line WAe001-A-12 using CRISPR/Cas9. Stem Cell Res. 2017 10; 24:89-93.
    View in: PubMed
    Score: 0.005
  16. Liu Y, Ruzi A, Guo D, Wu F, Liu H, Wu H, Wu Y, Yuan F, Zhuang Y, Yang F, Lai K, Lai L, Li YX. Generation of two MEN1 knockout lines from a human embryonic stem cell line. Stem Cell Res. 2017 10; 24:169-173.
    View in: PubMed
    Score: 0.005
  17. Liu Y, Wu F, Zhuang Y, Guo D, Abbas N, Wei R, Wang K, Chen Y, Tao J, Wu Y, Yuan F, Pan T, Yang F, Lai K, Lai L, Li YX. Generation of three miR-122 knockout lines from a human embryonic stem cell line. Stem Cell Res. 2017 10; 24:164-168.
    View in: PubMed
    Score: 0.005
  18. Liu H, Guo D, Ruzi A, Chen Y, Pan T, Yang F, Li J, Xu K, Zhou T, Qin D, Li YX. Testosterone improves the differentiation efficiency of insulin-producing cells from human induced pluripotent stem cells. PLoS One. 2017; 12(6):e0179353.
    View in: PubMed
    Score: 0.005
  19. Xu Y, Wu Y, Guo D, Gao G, Lai K, Yang F, Wang K, Wu H, Lai L, Li J, Xu K, Li YX. Generation of an ASGR1 homozygous mutant human embryonic stem cell line WAe001-A-6 using CRISPR/Cas9. Stem Cell Res. 2017 07; 22:29-32.
    View in: PubMed
    Score: 0.005
  20. Ho JC, Zhou T, Lai WH, Huang Y, Chan YC, Li X, Wong NL, Li Y, Au KW, Guo D, Xu J, Siu CW, Pei D, Tse HF, Esteban MA. Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A/C. Aging (Albany NY). 2011 Apr; 3(4):380-90.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.